Staging intrathoracic non-small-cell lung cancer

Area of Science:

• Oncology
• Radiology
• Medical Imaging

Background:

• Accurate staging of intrathoracic non-small-cell lung cancer (NSCLC) is crucial for treatment planning.
• Imaging plays a vital role in determining the extent of the primary tumor (T stage) and lymph node involvement (N stage).

Purpose of the Study:

• To outline the capabilities of various imaging techniques in staging NSCLC.
• To evaluate the effectiveness of computed tomography (CT), magnetic resonance imaging (MRI), and radionuclide imaging for NSCLC staging.
• To discuss emerging applications of ultrasound and endosonography in NSCLC assessment.

Main Methods:

• Review of current literature on imaging modalities for NSCLC staging.
• Appraisal of CT for detecting hilar and mediastinal lymph node metastases.
• Evaluation of MRI and radionuclide imaging for nodal and chest wall invasion.
• Consideration of ultrasound and endosonography for advanced staging.

Main Results:

• Computed tomography is the established standard for NSCLC staging, particularly for T and N staging.
• CT has limitations that necessitate the use of complementary imaging techniques.
• MRI and radionuclide imaging provide valuable information for assessing mediastinal and chest wall invasion.
• Ultrasound and endosonography show promise for future applications in NSCLC staging.

Conclusions:

• A combination of imaging techniques, with CT as the cornerstone, is essential for comprehensive NSCLC staging.
• Complementary modalities like MRI enhance the accuracy of staging, especially for local invasion.
• Further research into novel imaging applications will improve NSCLC patient management.